Newcelx Ltd (NCEL)

$3.42 +0.07 (2.09%)
Market Cap 15.27M
Revenue (ttm) 0.00
Net Income (ttm) -1.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 21,000
Avg Vol 38,428
Day's Range N/A - N/A
Shares Out 4.56M
Stochastic %K 35%
Beta 0.12
Analysts Strong Buy
Price Target N/A

Company Profile

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

Industry: Biotechnology
Sector: Healthcare
Phone: 41 44 512 21 50
Fax: 41 44 512 21 51
Website: newcelx.com
Address:
The Circle 6, Zurich, Switzerland
TomSwings
TomSwings Apr. 30 at 12:21 AM
$NCEL on watch
0 · Reply
yoni30
yoni30 Apr. 28 at 9:33 PM
$NCEL Just as the stock rose quickly and sharply, it fell quickly and sharply Until the experiment starts, we will probably see this
0 · Reply
Trekingirl
Trekingirl Apr. 27 at 9:52 PM
$NCEL Sold last week. Back in.
0 · Reply
Zardiw
Zardiw Apr. 27 at 4:23 PM
$YAAS - Called before Run - #DDAmanda Chart Also found early: $REPL $TZOO $NCEL Lots more at: https://DDAmanda.com
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 12:58 PM
$ELDN also eyeing the NewcelX partnership for Type 1 Diabetes. This would potentially address the supply bottleneck for islet transplants and fundamentally change ELDN’s valuation. We just need $NCEL’s drug to advance.
1 · Reply
topstockalerts
topstockalerts Apr. 23 at 11:34 PM
Top Gainers PT2 $SST $NCEL $AMST $BURU $WYHG
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 8:35 PM
Top Gainers $EUDA $TDIC $NCEL $CPIX $AMST
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 8:01 PM
$NCEL not the biggest move today, but definitely one of the cleanest
0 · Reply
moneywellspent
moneywellspent Apr. 23 at 7:49 PM
$NCEL strong accumulation here
0 · Reply
amir10
amir10 Apr. 23 at 7:46 PM
$IONQ take profits to $NCEL
0 · Reply
Latest News on NCEL
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

Apr 20, 2026, 7:37 AM EDT - 9 days ago

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing

Apr 1, 2026, 7:21 AM EDT - 4 weeks ago

NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

Mar 9, 2026, 7:00 AM EDT - 7 weeks ago

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

ELDN

NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy

Feb 12, 2026, 7:00 AM EST - 2 months ago

NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy

NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences

Jan 29, 2026, 7:00 AM EST - 3 months ago

NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences

NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression

Jan 12, 2026, 7:00 AM EST - 3 months ago

NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression

NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board

Jan 5, 2026, 7:00 AM EST - 4 months ago

NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

Dec 11, 2025, 7:00 AM EST - 4 months ago

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

Nov 17, 2025, 7:00 AM EST - 5 months ago

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board

Nov 6, 2025, 7:00 AM EST - 6 months ago

NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board

NewcelX CEO Issues Letter to Shareholders

Nov 4, 2025, 7:00 AM EST - 6 months ago

NewcelX CEO Issues Letter to Shareholders

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

Nov 3, 2025, 8:25 AM EST - 6 months ago

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

NLSP

TomSwings
TomSwings Apr. 30 at 12:21 AM
$NCEL on watch
0 · Reply
yoni30
yoni30 Apr. 28 at 9:33 PM
$NCEL Just as the stock rose quickly and sharply, it fell quickly and sharply Until the experiment starts, we will probably see this
0 · Reply
Trekingirl
Trekingirl Apr. 27 at 9:52 PM
$NCEL Sold last week. Back in.
0 · Reply
Zardiw
Zardiw Apr. 27 at 4:23 PM
$YAAS - Called before Run - #DDAmanda Chart Also found early: $REPL $TZOO $NCEL Lots more at: https://DDAmanda.com
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 12:58 PM
$ELDN also eyeing the NewcelX partnership for Type 1 Diabetes. This would potentially address the supply bottleneck for islet transplants and fundamentally change ELDN’s valuation. We just need $NCEL’s drug to advance.
1 · Reply
topstockalerts
topstockalerts Apr. 23 at 11:34 PM
Top Gainers PT2 $SST $NCEL $AMST $BURU $WYHG
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 8:35 PM
Top Gainers $EUDA $TDIC $NCEL $CPIX $AMST
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 8:01 PM
$NCEL not the biggest move today, but definitely one of the cleanest
0 · Reply
moneywellspent
moneywellspent Apr. 23 at 7:49 PM
$NCEL strong accumulation here
0 · Reply
amir10
amir10 Apr. 23 at 7:46 PM
$IONQ take profits to $NCEL
0 · Reply
YoungBullMoney
YoungBullMoney Apr. 23 at 7:34 PM
seeing big traders are calling $ADVB now.. its breaking out.. @TopStockAlerts has about 110,000 Followers on Stocktwits and is now on ticker ADVB Amazing breakout .. ADVB has only about 600k shares outstanding to public Looks like Bulls from $TDIC $TRT $NCEL are moving to --> ADVB
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 7:32 PM
$NCEL new HOD 🙌
0 · Reply
Crypto_Cartel
Crypto_Cartel Apr. 23 at 7:26 PM
$NCEL
0 · Reply
RETAlerts
RETAlerts Apr. 23 at 7:16 PM
$NCEL up 9.4% — tight float mechanics at work. Fewer shares available = amplified moves on volume. This is textbook squeeze set...
0 · Reply
topstockalerts
topstockalerts Apr. 23 at 7:02 PM
Top Gainers $EUDA $TDIC $CPIX $AUUD $NCEL
0 · Reply
Trekingirl
Trekingirl Apr. 23 at 5:15 PM
$SKLZ oh my! What a day! Good times! $NCEL
0 · Reply
Trekingirl
Trekingirl Apr. 23 at 4:56 PM
$NCEL Holy fuck! And Yee Haw!
0 · Reply
sethsethsethseth
sethsethsethseth Apr. 23 at 4:40 PM
$NCEL go go go
0 · Reply
McLarkin
McLarkin Apr. 22 at 4:41 PM
$NCEL why am I already up 50% in a week? Only just dipped in here.. was not expecting so fast a rise after the small equity raise..
0 · Reply
Jdorkshire
Jdorkshire Apr. 21 at 8:28 PM
$NCEL Great close, expecting gap tomorrow
0 · Reply
Crypto_Cartel
Crypto_Cartel Apr. 21 at 3:00 PM
$NCEL
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 20 at 11:37 AM
$NCEL NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
0 · Reply